United Therapeutics (UTHR) Accumulated Expenses (2009 - 2025)
United Therapeutics (UTHR) posted Accumulated Expenses of $480.9 million for Q4 2025, up 42.07% sequentially from $338.5 million in Q4 2024, and up 42.07% YoY from $338.5 million in Q4 2024.
United Therapeutics (UTHR) Accumulated Expenses (2009 - 2025) Analysis & Trends
United Therapeutics has reported Accumulated Expenses for 17 years, with the latest figure at $480.9 million in Q4 2025.
- Quarterly Accumulated Expenses rose 42.07% year-over-year to $480.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $480.9 million (up 42.07% YoY) and the FY2025 annual result came in at $480.9 million, up 42.07% from the prior year.
- Accumulated Expenses rose to $480.9 million in Q4 2025 per UTHR's latest filing, from $338.5 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $480.9 million in Q4 2025 and troughed at $170.8 million in Q4 2021.
- A 5-year average of $301.7 million and a median of $292.4 million in 2023 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2021 and 2025: Accumulated Expenses decreased 6.62% in 2021, then jumped 42.07% in 2025.
- Over 5 years, Accumulated Expenses stood at $170.8 million in 2021, then soared by 32.2% to $225.8 million in 2022, then gained by 29.5% to $292.4 million in 2023, then increased by 15.77% to $338.5 million in 2024, then surged by 42.07% to $480.9 million in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $480.9 million, $338.5 million, and $292.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 480.90 Mn |
| Dec 31, 2024 | 338.50 Mn |
| Dec 31, 2023 | 292.40 Mn |
| Dec 31, 2022 | 225.80 Mn |
| Dec 31, 2021 | 170.80 Mn |
| Dec 31, 2020 | 182.90 Mn |
| Dec 31, 2019 | 138.50 Mn |
| Dec 31, 2018 | 143.00 Mn |
| Dec 31, 2017 | 162.70 Mn |
| Dec 31, 2016 | 96.10 Mn |
| Dec 31, 2015 | 95.90 Mn |
| Dec 31, 2014 | 78.39 Mn |
| Dec 31, 2013 | 85.54 Mn |
| Jun 30, 2013 | 81.73 Mn |
| Mar 31, 2013 | 67.34 Mn |
| Dec 31, 2012 | 72.99 Mn |
| Sep 30, 2012 | 87.64 Mn |
| Jun 30, 2012 | 67.21 Mn |
| Mar 31, 2012 | 58.59 Mn |
| Dec 31, 2011 | 57.23 Mn |